Guimeixin Enteric-coated Capsules

The mechanism of action of this product is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase, inhibit the action of inflammatory active substances to produce analgesic effects, and inhibit the chemotaxis of leukocytes and the release of lysosomes to inhibit inflammatory symptoms. Due to the inhibition of prostaglandin synthesis and release in the hypothalamic temperature regulation center, peripheral vasodilation and sweating are caused, which increases heat dissipation and produces an antipyretic effect.

The main ingredient of this product is indolacin

This product is an enteric-coated capsule containing yellow powder or crystalline powder.

Used for acute and chronic rheumatoid arthritis, rheumatoid arthritis, ankylosing spondylosis and other inflammatory pain.

Oral administration: 2 capsules at a time, 3 times a day, increase to 4 capsules each time if necessary.

1. Gastrointestinal reactions: nausea and vomiting; 2. Inhibition of the hematopoietic system: granulocytopenia, etc., occasionally aplastic anemia.

1. Patients who are allergic to this product, aspirin or other non-steroidal anti-inflammatory drugs are prohibited from using this product. 2. Patients with gastrointestinal ulcers are prohibited from using this product. 3. Patients with tremor paralysis are prohibited from using this product. 4. Patients with mental illness are prohibited from using this product. 5. Patients with bronchial asthma are prohibited from using this product. 6. Patients with liver and kidney dysfunction are prohibited from using this product. 7. Pregnant women and lactating women are prohibited from using this product.

Precautions for children: Children should not take this medicine. If it must be used, follow the doctor's advice. Precautions for pregnancy and lactation: Pregnant and lactating women are prohibited. Precautions for the elderly: Elderly patients are prone to kidney toxicity and should be used with caution.

1. Long-term combined use with acetaminophen can increase renal toxicity. When used in combination with other non-steroidal anti-inflammatory drugs, the incidence of gastrointestinal bleeding increases. 2. When used with aspirin or other salicylic acid drugs, it does not enhance the therapeutic effect, but significantly increases gastrointestinal adverse reactions. Due to the enhanced inhibition of platelet aggregation, it can increase the bleeding tendency.

Keep away from light and store in sealed container.

0.15g

24 months

Longhui Phamaceufical Co., Ltd.

• Founded in:

  2005-08-16

• Address:

  Gongnong Street, Fulaerji District, Qiqihar City, Heilongjiang Province

• Tax NO.:

  912302007778660655

• Registered Funds:

  144.4759 million yuan

• Email:

  Log in to view